Health
UAE company nears end of Chinese Covid-19 vaccine trial – Arab News
ABU DHABI: A United Arab Emirates company is nearing the end of Phase III clinical trials of a Chinese COVID-19 vaccine and hopes to manufacture it next year, a…
ABU DHABI: A United Arab Emirates company is nearing the end of Phase III clinical trials of a Chinese COVID-19 vaccine and hopes to manufacture it next year, a representative said.The trial, which began in mid-July, is a partnership between Sinopharms China National Biotec Group (CNBG) and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42).The vaccine uses an inactivated virus; a well-known technology which has been used against diseases such as influenza and mea…
-
General20 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Business23 hours agoWhy this ASX 200 tech stock could rise 20%
-
Noosa News23 hours agoStruggling AFLW teams GWS, Collingwood and Gold Coast receive extra picks or list spots from league
-
Noosa News22 hours agoNSW records 100th e-rideable battery fire for 2025, prompting renewed safety calls